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Grouping of large populations into few CTL immune
‘response-types’ from influenza H1N1 genome
analysis
Sumanta Mukherjee1 and Nagasuma Chandra1,2
Despite extensive work on influenza, a number of questions still remain open about why individuals are differently susceptible
to the disease and why only some strains lead to epidemics. Here we study the effect of human leukocyte antigen (HLA)
genotype heterogeneity on possible cytotoxic T-lymphocyte (CTL) response to 186 influenza H1N1 genomes. To enable such
analysis, we reconstruct HLA genotypes in different populations using a probabilistic method. We find that epidemic strains in
general correlate with poor CTL response in populations. Our analysis shows that large populations can be classified into a
small number of groups called response-types, specific to a given viral strain. Individuals of a response-type are expected to
exhibit similar CTL responses. Extent of CTL responses varies significantly across different populations and increases with
increase in genetic heterogeneity. Overall, our analysis presents a conceptual advance towards understanding how genetic
heterogeneity influences disease susceptibility in individuals and in populations. We also obtain lists of top-ranking epitopes
and proteins, ranked on the basis of conservation, antigenic cross-reactivity and population coverage, which provide ready short-
lists for rational vaccine design. Our method is fairly generic and has the potential to be applied for studying other viruses.
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Influenza virus (IFV) is engaged in an arms-race with its host,
evolving rapidly often under negative selection.1,2 Consequently, there
exists a large pool of closely related viral strains yet diverse enough to
be differently virulent,2 affecting different human populations
differently.3 Some strains turn out to be so highly virulent that they
have caused epidemic outbreaks in some regions, causing many
deaths, such as the 19184 and 20095,6 outbreaks. It is well understood
that influenza is controlled either by antibodies or CD8þ T-cells.1,7–9
In fact, one of the vaccine strategies currently being tested involves
inactivated IFVs capable of inducing cytotoxic T-lymphocyte (CTL)
responses.1,10 Individuals differ significantly in their ability to respond
to an infection. Among the factors that govern the outcome of an
infection, human leukocyte antigen (HLA) polymorphism in the host
is one of the most important.11 A few associations between HLA allele
types and susceptibilities to different diseases have been discovered
through a variety of approaches, including linkage analysis and
genome-wide association studies.12,13 No such clear associations are
well known for influenza. There is, however, a recent report that links
A*24 allele to H1N1 infection.14 Although pathogen diversity remains
a main cause for heterogeneity in disease outcome, host genetic
heterogeneity is another important cause, making host responses
highly complex in nature, yet inadequately studied.
Typically in humans, each individual carries two sets each of HLA
A, B and C alleles, co-dominantly.15 Based on the precise combination
of HLA alleles, individuals differ from each other in their immune
potential and hence in the susceptibility to a given infection. HLA
alllele frequencies in different ethnic groups have been determined by
extensive sequencing of alleles and has been documented in public
databases.16,17 A large amount of data has been accumulated about
the viruses too, including genome sequences of hundreds of strains.18
Major advances have also occurred on the epitope mapping front,
with several well-validated methods for prediction of strong epitopes
from genome sequences.19,20 Clinical data about the severity of the
disease in different locations and strains that have led to outbreaks are
also available from different resources.5
Despite these advances, much needs to be understood about how
host HLA diversity affects disease susceptibilities. Particularly, there
are no clear answers for why different individuals show varied
susceptibility, why does the presence of a high-risk allele not always
lead to the same extent of disease susceptibility, why some individuals
with different HLA alleles show similar CTL responses to a given
pathogen, why do some variations in the pathogen genome trigger
major differences in response while some others do not and why do
some strains cause outbreaks but not all? Clearly these are complex
questions. The complexity due to the number of HLA polymorphs
and also the complex pattern of interactions with epitopes makes it
necessary to employ computational approaches to obtain global
perspectives. In this study, we seek to address some of these questions
through a molecular systems approach starting with mining ‘big
data’from literature and then using the insights obtained from that to
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investigate the effect of heterogeneity in a population in terms of the
impact it makes on recognizing a pathogen.
Data we use are (a) the set of CTL epitopes from different strains of
IFV along with their cognate HLA alleles, (b) genome sequences of
hundreds of IFV strains presenting strain variation and (c) host
heterogeneity in terms of allele frequencies in different populations.
Making use of the vast data on these from IMGT16 and IEDB21
resources, through computational analyses, we show that despite high
extents of diversity or polymorphism in HLA genotypes, different
individuals can be grouped into a small number of response-types,
typing being pathogen and strain-specific. Individuals in a response-
type theoretically ‘see’ the IFV in a similar way. Strains that have
caused epidemics are predicted to elicit very poor response in the
corresponding population, due to the low number of epitopes to the
HLA alleles in that population. Some populations show high response
to all the studied strains, indicating very low incidences of H1N1
infections. Rank lists of strains, epitopes, alleles, and populations
based on the expected CTL response are obtained, which can serve as
useful pointers for vaccine design. Finally, we show the effect of
heterogeneity in hypothetical populations in terms of CTL response
to IFV and that heterogeneity in populations could help in restricting
the spread of H1N1 influenza.
RESULTS
Genome-wide epitope detection and viral strain diversity
The CD8þ immunome of IFV was identified using three well-
established methods from IEDB,22–24 from which consensus
predictions were obtained. Example consensus epitopes for strain
A/mallard/Alberta/965/1979 are listed in Supplementary Table 1, and
data for all strains are made available on a web resource FluTope
(http://proline.biochem.iisc.ernet.in/flutope). Forty-one of the pre-
dicted epitopes are seen to match exactly with those identified
experimentally from various biochemical binding and T-cell stimula-
tion studies in literature21,25 (Supplementary Table 2). The epitope
positions and their conservation patterns in each protein are shown in
Figure 1, along with a scatter plot of epitope-based distances versus
whole-genome sequence-based distances. It is seen that, on the whole,
epitope regions as compared with whole polypeptide chains show
higher variation across strains, indicating the significance of these
regions and the selection pressure leading to mutations. We note that
variation cannot be uniform for all epitopes in a protein as it will be
determined by both selection pressure due to antigenicity and extent
of mutability of the particular residues in order to retain protein
structure and function. Indeed, we observe a small set of highly
conserved epitopes in some proteins, particularly PB2 and PB1
(Supplementary Tables 3 and 10). For some viral proteins such as
PB1 and PA, it is interesting to observe that some strains form
separate clusters (Figure 1; Supplementary Figure 5), indicating
higher variation and higher host-immune selection pressure in such
strains. This is similar to antigenic shifts for B-cell antigens reported
for other IFV subtypes.26
Epitope pools vary in size in different strains (distribution in
Supplementary Figure 1a), despite retaining similar overall length of
each protein. Figure 2a illustrates the relative number of epitopes
from each protein along with the major alleles that they recognize for
one example strain. Similar figures for all 186 strains are in FluTope. It
is seen that the major alleles that recognize IFV epitopes vary in the
range of 10–12 for different strains. Biclustering performed to capture
cross-reactivity between epitopes and the alleles is shown in Figure 2b
for one example strain, indicating a relative ranking of the theoretical
potential of different alleles and pool of epitopes from different
proteins in generating a CTL response. A dendrogram of 186 IFV
strains, based on the extent of similarities in their epitope sets for each
protein (Supplementary Table 4a) is seen to be different from those
constructed based on sequence similarities in whole proteins
(Supplementary Table 4b). These branching patterns, with higher
number of branches in epitope trees, indicate that even subtle
variations in the genome can give rise to significant differences in
the CD8þ immunomes.
Modelling host diversity
Next, we model host diversity by reconstructing all possible HLA
genotypes in a population. About 1884, 2490 and 1384 HLA genes are
listed for A, B and C loci, respectively, leading to an astronomical
B4.6 quintillion genotypes. Although, such a large number of
genotypes are theoretically possible, available data suggest that only
about a hundred alleles are known to occur predominantly, leading to
a much reduced but still daunting number of combinations of about
1.2 million genotypes. The number becomes even smaller when allele
frequencies in individual ethnic groups are considered. Variations in
allele frequencies in 59 ethnic groups are collated from public
repositories17 (shown in FluTope). The distribution provides a basis
to understand allele frequencies in a population and point to the
expected propensity of each allele in an individual’s HLA genotype. A
further filtering in the list of alleles that can be considered comes from
the extent of information available on the epitopes an allele can bind.
Based on such data and application of well-tested and benchmarked
algorithms for epitope prediction from the IEDB resource, it is
currently possible to study 79 HLA Class-1 alleles (29, 28 and 13 A, B
and C, respectively). Hence further analysis in this study is restricted
to these 79 alleles and the genotypes that can be constructed from
them. These 79 are among the most predominant alleles listed in
IMGT. The number of genotypes thus constructed (see
Supplementary Algorithm 1) differ for different populations and
range from 313 for ‘Brazil Mixed’ to 4858 for ‘USA North American
Natives’ (see Supplementary Figure 2).
A dendrogram is constructed from all-pair distances of populations
of 59 ethnic groups by considering extent of dissimilarity in the HLA
alleles in the genotypes of each population (see Supplementary Figure
S3). Each node represents an ethnic group, and distances between
nodes indicates extent of difference in their HLA distribution profiles.
Their arrangement into clades tells us which leaves are most similar to
each other. We observe, for example, clustering of ‘Brazil Mixed’ and
‘Italy Population 2’ in the same clade while ‘USA Arizona Gila River
American’ and ‘Australia Yuendumu Aborigin’ cluster together in
another clade. Observation of such clades would imply that, in
general, populations in the respective leaf nodes are likely to respond
to any given pathogen in a similar manner. However, it must be
pointed out that differences in genotypes is a first-level description of
the host diversity for CD8þ immune responses, but their specific
responses will depend upon not only the host HLA genotypes but also
on the epitope set counterpart from the specific pathogenic strain.
Although similar genotypes are expected to respond similarly, it is
possible that different HLA genotypes can also recognize a given
pathogen in a similar fashion.
Grouping populations into ‘response-types’
As the next step therefore, we map epitopes from each strain of IFV
for each individual HLA genotype in a population and compare
similarities between different ethnic groups by considering the
corresponding pools of epitopes of their component alleles. Our
predictions show that, on an average, an individual recognizes about
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14 epitopes (Supplementary Figure 1b), the number varies from 0 to
109 for different individuals in all populations (all data in FluTope).
We perform clustering of different HLA genotypes in a population on
the basis of commonality in the epitope pools that they recognize. We
observe for all 59 ethnic groups studied here thousands of HLA
genotypes in each group indeed cluster into only a few types. We refer
to these clusters as ‘response-types’ (Figure 3a). The number of
clusters in individual ethnic groups vary from as few as 2 to about 20
Figure 1 Epitope conservation in 186 strains of Influenza A virus. Positions of consensus epitopes in 186 strains of IFV for proteins PB1 and NP are shown
(Supplementary Figure 6 shows similar figures for other 6 proteins as well). Protein names are labelled. Rows represent different strains in the order in
which they are listed in the database (Supplementary Table 1a) while columns represent amino-acid residues along the length of the polypeptide chain of
the corresponding protein. Each protein from different strains is aligned by multiple sequence alignment using Muscle. Consensus epitopes, each of 9 aa
length are indicated in red. Marked below the alignment for each protein, in green, is a measure of Shannon entropy indicating the extent of sequence
variability. Scatter plots of whole protein-sequence based distances of all-pairs of strains (x axis) against epitope-based distances for the same pairs of
strains (y axis) is given for all eight proteins. The scatter is predominant in the upper part of the diagonal, as is evident in all cases, indicating higher
variation in epitope regions.
CTL response-types from H1N1 genome analysis
S Mukherjee and N Chandra
3
Clinical & Translational Immunology
(see Supplementary Figure 4). Figure 3b illustrates a hierarchical
diagram, reflecting relative ranking of proteins, epitopes and the
alleles they recognize in a given population. As an example, for 1034
HLA genotypes in Mexican population, there are only 15 different
response-types. This grouping varies for different strains in a given
population and for different populations in response to a given strain
(Supplementary Figure 4). Higher the number of response-types
signifies the strong effect of genetic heterogeneity in the pathogen
recognition.
Effect of viral strain diversity and host heterogeneity on overall
CTL response
Next, we evaluated the effect of strain diversity on the stability of the
clusters or response-types by analysing different strains of the virus.
Through this analysis, we study whether a given response-type,
derived from the study of one viral strain, holds good generally for
other strains as well. Stable clusters can result from one of the
following: (a) minimal changes in the epitope regions of the viral
strains, and (b) similar overall recognition by a given population
despite changes in epitope regions, accounted for by cross-reactivities.
Figure 4 illustrates an example of stability diagram for Japanese
population for five viral strains. Different strains show different
epitope set sizes for a given population. Major epidemic outbreaks
(Supplementary Table 9) are reported for A/Japan/921/2009 and A/
Mexico/4486/2009 strains, which correlate well with the least size of
the epitope set (all data in FluTope) indicating that these strains
exhibit least number of epitopes for these alleles seen in the given
population and hence show poor CTL responses. The number of
clusters representing response-types are seen to reduce dramatically
for epidemic strains, while they are reasonably robust for all other
strains (all data in FluTope).
Figure 5 illustrates a 3D ranked plot of variation of total CTL
response for 59 different populations for 45 selected strains. Total
response is seen to vary from high to low across strains and
populations, which is clearly poor for some ethnic groups and some
strains, suggesting that some populations are strong CTL responders,
whereas others are not, at least for the set of strains studied here.
African nations are examples of the former while Chinese and
Vietnamese are examples of the latter. Likewise, variations in total
response across strains is also clearly evident. Two observations
emerge for epidemic strains: (a) in general the total response in the
population is seen to be poor, and (b) such populations contain very
few response-types for that strain, as a result of which there is more
homogeneous but overall very poor total response (see
Supplementary Figure 5).
Based on overall response, we compute ranked lists of (a) major
epitopes that can be recognized by one allele or another in a given
population, (b) major alleles that contribute to the recognition in
each ethnic group and (c) proteins or individual subunits that contain
the largest number of epitopes that can be recognized by the largest
number of alleles in a given population (Supplementary Tables 5–8).
From this, we see that viral proteins PB1 and NP, alleles B*15:01,
B*58:01, A*30:01, A*02:01 and A*32:01 are examples of major
responders. Interestingly, PB1 and NP have been reported earlier to
be the most antigenic proteins in ferrets.27–29
As pure populations of an ethnic group does not reflect the real
world accurately, we hypothetically reconstruct heterogeneous popu-
lations and studied the effect of heterogeneity on the total CTL
response. Figure 6 illustrates the predicted response for randomly
chosen combination of six ethnic groups to the same strain (results
for different combinations provided in FluTope). An increase in
response-types and non-linearity in extent of response is clearly
Figure 2 (a) Representation of the set of CD8þ epitopes on the IFV genome from consensus predictions. The innermost pie chart reflects the relative ratios
of the different HLA alleles that are theoretically capable of recognizing the given strain of the IFV. The outer doughnut represents the number of epitopes
for a pool of HLA alleles for each of the eight protein in the genome (size of the segments proportional to the number of epitopes). The histograms shown
outside the doughnut reflects the corresponding HLA cognate alleles for epitopes of that protein. Proteins are labelled while the HLA alleles are as indicated
in the colour key. (b) A biclustering diagram with columns representing different proteins in the viral genome and rows representing different HLA alleles
that recognize the set of epitopes in each protein. The colour in each cell indicates the predicted recognition strength, as a factor of the number of epitopes
in that protein for a given allele. Clustering patterns indicate similarity in responses both from an allele’s perspective as well as from a protein’s. The total
antigenicity in terms of the number of epitopes is indicated for each protein. Also indicated is the recognition strength of each HLA in terms of the number
of epitopes it can bind.
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evident with increasing heterogeneity. Some combinations are also
seen to confer more response than others. Overall, situations of very
poor response as in the case of epidemics can be avoided in
heterogeneous populations, hypothetically amounting to inducing
herd immunity naturally.
DISCUSSION
HLA genetic heterogeneity has been well addressed in literature,
which has resulted in many insights about the complex evolution,
including effect of balancing selection, influence of demographic
factors and past human migrations.30 For several diseases, specific
HLA alleles have been associated with increased or decreased
susceptibilities.12,14 However, little is known about the effect of
HLA heterogeneity in a population as a whole on susceptibility to
infectious diseases, such as influenza.
Many studies in literature consider one HLA allele at a time,
somewhat independent of the combinations they exist in. As the
entire HLA genotype in an individual will make an impact in
recognizing a given pathogen, here we consider each genotype as an
integrated unit and estimate its response to a given pathogen. Cross-
reactivity between HLA alleles and epitopes make one-to-many and
many-to-one associations between individuals or HLA genotypes and
proteins in the IFV, making it difficult to correlate susceptibility with
individual alleles. This problem is overcome by our approach, which,
based on molecular systems data of hundreds of viral strains together
with exhaustive reconstruction of HLA genotypes for different
populations, provides global perspectives of how individuals ‘see’
the pathogen. Our analysis shows that whole populations can be
grouped into only a few response-types, presenting a significant
conceptual advance as compared with considering single alleles
individually. Several insights are obtained from this study: (a) total
response to the epidemic strains is generally poor, due to both few
epitopes and low responder phenotypes, (b) grouping into response-
types is strain-specific, (c) only a few alleles possibly contribute to
CD8þ responses for IFV, (d) some ethnic groups are more vulnerable
than others for most strains of the virus as indicated in the ranked
lists, (e) ethnic groups that have a high extent of allele polymorphism
in their HLA genotypes consisting of the contributing alleles on the
whole show higher response than ethnic groups that show high
skewness in allele distributions, (f) on an average variation in total
response from a population across different strains is 10-fold higher
than response variation of a given strain across ethnicities, and (g)
Figure 3 Response-type analysis performed on Kentucky/96/2009 H1N1 strains for Japan Central population. (a) A network representation of HLA
genotypes (different individuals) in a population. Nodes (circles) represent response-type, which are clusters of HLA genotypes. Each genotype is denoted by
the human symbol, and they are clustered based on similarity in terms of epitopes they recognize. Despite clustering, a small amount of cross-presentation
of epitopes are seen between clusters (response-types) indicated as edges in the network (curved arcs). The overlap between clusters are very small
compared with the epitope pool recognized by a response-type. The size of nodes are proportional to the number of HLA genotypes that group into a cluster.
Each cluster is shown in a different colour. The workflow for deriving the response-type is also indicated. (b) An illustration of a hierarchical network
involving different interconnected levels. Level 1 represents the viral genome. Level 2 depicts viral proteins, each containing different number of Class-1
HLA epitopes shown in level 3. The size of each node in level 2 is representative of the epitope set size. Connections between levels 2 and 3 are shown
from the epitope to the protein(s) that contains it. The size of the nodes in level 3 represents the number of HLA alleles that particular epitope can bind to.
The top node is labelled. This level is in turn connected to level 4 that represents different HLA alleles that recognize the entire pool of epitopes on all
proteins in the influenza genome. HLA nodes are sized according to the number of epitopes they recognize. Different individuals contain different HLA
genotypes. Individuals are clustered together based on the extent of commonality in the pool of epitopes they recognize, which is shown in the top most
level (in purple). Each cluster represents a ‘response-type’. The size of the nodes representing a response-type indicates their relative importance in
recognizing the epitope pool from the pathogen. The histogram above reflects likelihood of the occurrence of each cluster in a given population based on
known allele frequencies. The red circles indicate extent of response of each response-type. Corresponding figures for all combinations of ethnic groups and
IFV strains can be obtained from the web resource FluTope.
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finally, as populations get heterogeneous, such as due to combinations
of ethnic groups, total response to the virus increases in general, thus
proportionately decreasing chances of susceptibility. Increasing het-
erogeneity in populations is clearly seen to increase robustness in the
pathogen recognition profile by substantially increasing overall
recognition levels in a mixed population of different ethnicities. It
seems plausible to understand how lack of heterogeneity in a
population can lead to epidemics if their HLA genotypes do not
contain the right alleles to recognize the pathogen, consistent with the
general notion of the importance of heterogeneity.
It is possible that our results, to some extent, are influenced by
some of the simplifying assumptions that have been necessary to carry
out this work. These are: (a) only A, B and C HLA alleles are
considered but not the non-classical alleles, (b) in an individual
different alleles are considered to be equally important for recognizing
a pathogen, provided suitable epitopes are available, and (c)
influences of either CD4þ or B-cell responses or interaction with
killer cells are not explicitly considered. Further, generating combina-
tions of HLA genotypes is an approximation and has not considered
selection pressures or any environmental triggers. The epitope set has
been derived from predictions and hence depends on prediction
accuracies. Although prediction accuracies are seen to be quite high, it
is possible that there are a small number of false positives and also
false negatives, especially for epitopes containing poorly characterized
patterns.31 Selection of only the consensus predictions of epitopes,
although greatly increases precision, comes at a cost of losing some
epitopes that are predicted by one or two but not all three methods.
Nevertheless, the omissions would form only a small fraction of the
data used and are unlikely to affect the conclusions in any significant
manner. In any case, the framework provided here, however, facilitates
easy incorporation of such data, when it becomes available, which
should be helpful in refining the analysis.
The analysis presented here provides a conceptual advance in
understanding population-wide T-cell responses to IFV and hence
disease susceptibilities. Pointers obtained from an analysis of this type
have the potential to be useful in a clinical setting in several ways. If
HLA genotype data of different populations and also the genome data
of different viral strains become commonly available, it will be
possible to explain differences between strains and between popula-
tions in terms of disease potential. For a given strain and a given
Figure 4 Influence diagram depicting cluster stability upon strain variation. The leftmost panel indicates strain diversity with the size of the circle
rendered proportional to the number of epitopes it has. They are clustered based on the extent of commonality in their epitope sets. Distribution of
HLA alleles that can recognize the epitope pool is indicated in the histogram where the number of epitopes a given allele can recognize is shown as the
frequency. Individuals in a given ethnic group are grouped into non-overlapping clusters (see Methods) on the basis of the number of epitopes
they recognize by their HLA genotypes. The number of clusters vary for each strain as the number of epitopes vary, which is shown in the right panel.
Thus, in a given row, information about CD8þ antigenicity from a given strain (left) and their inter-relatedness, the distribution of HLA alleles that can
recognize them (middle) and the number of response-types (people clusters) in a given ethnic group, the relative sizes of each response group (number
of people in that group) (right panel). Lines connecting the response groups between strains indicate the stability of the cluster based on the number
of common individuals in the group (which is based on the extent of commonality in the epitope pool for that group). Light grey lines indicate shared
epitopes between different response groups as strains diverge. Strains are ordered on the basis of their similarity to each other in terms of the epitope pools
and variation.
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population, lists of majorly contributing alleles in responder geno-
types can be obtained and simultaneously also a ranked list of
conserved epitopes, both useful for rational vaccine design. Assess-
ment of responsiveness of a genotype naturally leads to prediction of
disease susceptibility of an individual or a population to a given viral
strain. Future possibilities using this approach include study of co-
infections with multiple strains or even multiple viruses. Large-scale
data analytics is indeed leading to a powerful paradigm shift in
medicine, a shift from studying single molecules with a reductionist
philosophy to the study of systems and populations as a whole, to get
holistic perspectives of the systems’ behaviour. Insights obtained from
such models can ultimately translate into more rational strategies in
clinical practice.
METHODS
Nomenclature
HLA: refers to the human leukocyte antigen molecules that represent the major
histocompatibility complex in humans. Different HLA alleles in this study
represent different polymorphic forms of this molecule across A, B and C loci.
HLA genotype: refers to the set of six Class-1 HLA alleles, two each from A,
B and C loci, contained in an individual.
Epitope: refers to a typical Class-1 T-lymphocyte antigen of nine amino
acids length from one of the proteins of the IFV proteome.
HLA-pool: refers to the pool of all different HLA alleles considered in a
given population.
Epitope set: refers to the pool of all epitopes present in the given viral strain
that can be recognized by a HLA-pool.
Population: refers to a notional population of a given ethnic group of about
one million individuals. Heterogeneous populations are hypothetical con-
structs consisting of combinations of HLA pools in the indicated proportions
from different ethnic groups.
Response: refers to CTL response in an individual that would be expected by
the binding and downstream action of the given epitope set to the HLA
genotype. In populations, it refers to the expected effect from the binding of
the epitope set to the HLA pool of a given population.
Epidemic: refers to widespread occurrence of disease in a population at a
given time, as collated from cited literature.5,32
Mathematical notations
Let P represent the IFV proteome, consisting of various proteins, P¼ {p1, p2,...,
pm} where m is the number of proteins in the H1N1 genome. Each protein
contains multiple CD8þ epitopes, represented by Ei¼ {ei1, ei2,...ef(i)}, where Ei
is the epitope set for ith protein. H represents the HLA pool, H¼ {h1, h2,
yh3}, hx represents the individual alleles. The HLA mediated antigen response
is represented as a f-function. fðhi; elmÞ¼ 1 hi recognizes elm0 Otherwise

.
We have used set symmetric distance (~), to measure distance between any
two given set A and B given as A  B¼ # A nBð Þ[ B nAð Þgf # A[Bð Þ . This distance measure
is normalized between 0 and 1.
Genome analysis of the IFV and immunome definition
Genome sequence of IFV (H1N1) was obtained from UniprotKB.33,34 CD8þ
T-cell epitopes in the genome were identified by a consensus prediction
method based on three independent methods available through the IEDB
portal.35 The methods compute a consensus rank for the three individual
predictions based on (a) artificial neural network,22 (b) stabilizing matrix
method23 and (c) combinatorial peptide library-based method.24 Those
peptide segments that are identified as strong binders for any HLA Class-1
allele are considered as the set of epitopes. A peptide that binds to a HLA
molecule with a predicted IC50 of o50 nM is regarded as a strong binder. The
same exercise is repeated for 186 different strains of IFV, and the set of epitopes
from each of these are collected and further analysed. List of epidemic strains
were obtained from Expasy18 and FluDB36 (Supplementary Table 1).
Figure 5 A three-dimensional plot indicating 59 different ethnic groups on one axis, 45 selected viral strains on the other axis and the total CTL response
on the z axis (height of each bar). Each ethnic group response is plotted in a distinct colour. Only 45 out of the 186 strains are shown for clarity in the
figure. These are obtained by uniform sampling from a ranked plot of all 186 strains’ list. The plot is sorted on the total average response of a given strain
across different populations. The first row corresponding to 45 strains is seen to have the least response by any population. Ethnic group ‘China Yunnan
Province Bulang’ in this set shows the poorest response to the strains studied while ‘Uganda Kampala’ shows the highest response. The height of each bar
indicating overall CTL response is based on the pool of epitopes in the strain that can be recognized by the set of HLA genotypes in that population
grouped into response-types.
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Computing epitope-based distances and phylogenetic distances of
pairs of IFV strains
Let pi1 ; p
i
2;   pim
 
represent set of viral proteins, where the number of
distinct protein count is m. Protein sequence obtained from different strains
are aligned using MUSCLE,37 a k-mer based progressive alignment
algorithm. Let lj be the length of the j
th protein. aij;l represents the amino
acids at lth location, on the aligned sequence length, obtained from jth
protein from strain i. Eij represents the epitope sites in the j
th proteins from
strain i. Therefore unigram set presenting the sequence j from strain i is
k i; jð Þ¼ aij;n
 
n¼1li
and unigram presenting the epitopes’ sequence in
protein i is kE i; jð Þ¼ aij;n
 
n2Ei
j:
.
We measure the sequence distance in protein j from any two strains i1 and i2
and are given as k(i1, j)~k(i2, j). Similarly, the distance only in the epitope
segments are given as kE(i1, j)~kE(i2, j).
As mutation rates at different sites are distinct, we used positional Shannon
Entropy38 to measure the extent of variation at any particular site. The
measure of entropy for jth protein at site l is given by
H j; lð Þ¼P i2AA pji;l ln ðpji;lÞ, where AA represents the set of all possible
amino acids and p
j
i;l represents frequency of i
th amino acid at position l in
protein j.
Reconstruction of HLA genotypes in a population
Distribution of HLA pool in a given population is given as E. E assigns a
probability measure for every hi. An individual will have three pairs of HLA
genes (A, B and C loci, respectively).The probability of occurrence of HLA hi,
in a population is given as E(hi). Therefore SiE(hi)¼ 1, over each group of
HLA genes.
We assume the occurrence of HLA genes in an individual
is an independent event, S(i)¼ {h1(i),h2(i),h3(i),h4(i),h5(i),h6(i)}
represents six HLA genes present in ith individual, which we
refer to as HLA genotype. By independence assumption, the
likelihood of an individual present in the population with HLA set S(i)
can be estimated as L S ið Þ
 ¼Q6j¼1 E hj ið Þ . As we consider a finite-sized
population, we reject HLA genotypes with likelihood o1e6. This
approach is similar to the method used in IEDB population coverage
analysis.39
Distance between ethnic groups
Let Ei and Ej represent HLA genotype distributions of two ethnic groups,
obtained by considering allele frequencies in the individual ethnic groups. The
distance between two ethnic HLA distributions is given as
EiEj
		 		¼ ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiPmk¼1 Ei hkð ÞEj hkð Þ 2q :
Figure 6 Barycentric plots illustrating the effect of heterogeneity on total recognition response to IFV. Seven ethnic groups have been considered. In each
plot, vertices represent recognition response (red: strong , blue: weak) of a pure ethnic group. Each cell represents response of a particular HLA distribution
obtained by linear combination of different pure ethnic groups to varying extents such that the centre of the plot is a well-mixed population with equal
contributions from all ethnic groups in terms of the HLA distributions while the outermost grid at each vertex indicates response from the pure ethnic
groups.
CTL response-types from H1N1 genome analysis
S Mukherjee and N Chandra
8
Clinical & Translational Immunology
Comparison of total epitope pools between individuals within and
across populations
Epitopes recognized by an individual in a given population is called epitope
set, L(S(i))¼ {eij 8 f(hk,eij)¼ 1, where hk AS(i)}. Thus individuals can be
represented by the set of recognized epitopes in the pathogen recognition
space. LetW¼ {eij} be the epitope set for a given ethnic group E and pathogen
P. m is the number of pathogen proteins in the strain P. We represent an
individual l in pathogen recognition space as Xl A Rm ,where Xl¼ {xi}i¼ 1ym,
xi¼ #{eik 8eik A W and {f(hu, eik)¼ 1 8 hu A S(l)}}.Therefore, in this vector
representation, Xl each dimension represents recognition strength or the total
number of epitopes of a given viral protein.
Response group and stability analysis
Individuals are further clustered into response-types R¼ {r1, r2yrt}. Indivi-
duals of a given response-type are expected to recognize the pathogen in a
similar fashion. R partition the population space into non-overlapping classes,
ri-rj¼F 8 iaj. The grouping into non-overlapping clusters were performed
by Lloyd’s K-mean clustering. The estimation for appropriate value t value is
obtained using the Elbow method.40
Given an ethnic HLA distribution E, the population space remains the
same. Response groups’ partitioning of population space are determined by the
epitope sets. Epitope sets vary with the viral strains. If P1 and P2 are two viral
strains, giving rise to E1 and E2 epitope pool, restrained by the selected HLA
alleles, present in E. R1 and R2 are the response-type partitions. G is the map
function, between two response-type partitions. Let, Z1 and Z2 represents the
partitions sizes of R1 and R2, respectively.
G ri jR1ð Þ¼ max ri  r
r 2 R2
. G maps the
response-type correspondences, by maximum overlap between the two
partitions. G need not generate one to one map, as in many cases the
response-types merges or splits into subtypes on changing the pathogenic
strains. Under such situations, it generates one to many or many to one maps.
We define a distance between two partitions as bd R1;R2ð Þ¼ 1Z1 P
r2R1
r  rR2G rð Þ.
Similarly, the distance between the viral strains are given by their
epitope pools as d(E1,E2)¼E1~E2. The stability of the cluster is
defined as
bd R1 ;R2ð Þ
d E1 ;E2ð Þ.
Generating hypothetical mixed population model
E1 and E2 are two given HLA distributions, pertaining to two pure ethnic
groups. A drift in population HLA distribution from one pure profile to
another pure profile can be modelled by a simple affine combination, E1-
2(l)¼ lE1þ (1l)E2 , where lA(0, 1) is a parameter capturing the extent of
genetic drift. Drift between multiple HLA profile can similarly be modelled as
SjljEj, such that Sjlj¼ 1. For each value of l, resulting in HLA distribution
E(l), it generates a specific population genotype distribution.
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